You are here: Home » Current Affairs » News » National

LIVE: 25 states/UTs reduced VAT on petrol and diesel so far, says Centre

Covaxin, a vaccine developed in India, was found to have a 77.8 per cent efficacy rate against symptomatic Covid-19, said The Lancet

Topics
Today News | Coronavirus | Vodafone Idea

BS Web Team  | New Delhi 

EVENT HIGHLIGHTS

GST on petroleum
Negotiators at the UN climate summit in Glasgow are expected to lock horns on Friday for what is scheduled to be the final day of bargaining over how to stop global warming from becoming catastrophic.

Tata Steel has reported a consolidated net profit of Rs 11,918 crore in the September quarter, up nearly eight-fold or 661 per cent from the same period last year. The company overtook Tata Consultancy Services (TCS) to become the most profitable company in the Tata Group.
 
Covaxin, a vaccine developed by India’s government medical research agency and Bharat Biotech International Ltd., was found to have a 77.8 per cent efficacy rate against symptomatic Covid-19 in an analysis published in The Lancet. "Further research is needed to determine the vaccine’s long-term safety and effectiveness…,” said the journal.

CATCH ALL THE LIVE UPDATES

Auto Refresh